Stryker Corporation (NYSE:SYK) Shares Acquired by Board of the Pension Protection Fund

Board of the Pension Protection Fund grew its holdings in Stryker Corporation (NYSE:SYK - Free Report) by 425.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,100 shares of the medical technology company's stock after purchasing an additional 1,700 shares during the quarter. Board of the Pension Protection Fund's holdings in Stryker were worth $782,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Mascoma Wealth Management LLC grew its stake in shares of Stryker by 22.7% in the fourth quarter. Mascoma Wealth Management LLC now owns 146 shares of the medical technology company's stock worth $53,000 after acquiring an additional 27 shares in the last quarter. Lindbrook Capital LLC boosted its holdings in Stryker by 2.0% in the fourth quarter. Lindbrook Capital LLC now owns 1,407 shares of the medical technology company's stock valued at $507,000 after purchasing an additional 28 shares during the period. Continuum Advisory LLC grew its stake in Stryker by 5.8% during the 1st quarter. Continuum Advisory LLC now owns 532 shares of the medical technology company's stock worth $198,000 after purchasing an additional 29 shares in the last quarter. United Community Bank increased its holdings in Stryker by 3.4% during the 4th quarter. United Community Bank now owns 904 shares of the medical technology company's stock worth $325,000 after purchasing an additional 30 shares during the period. Finally, Ironwood Investment Counsel LLC increased its holdings in Stryker by 0.9% during the 4th quarter. Ironwood Investment Counsel LLC now owns 3,323 shares of the medical technology company's stock worth $1,196,000 after purchasing an additional 30 shares during the period. Institutional investors and hedge funds own 77.09% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on SYK shares. Citigroup restated a "buy" rating and set a $455.00 target price (up from $443.00) on shares of Stryker in a research note on Thursday, May 22nd. Needham & Company LLC reiterated a "buy" rating and set a $442.00 price target on shares of Stryker in a report on Friday, March 21st. Evercore ISI dropped their price objective on shares of Stryker from $400.00 to $390.00 and set an "outperform" rating on the stock in a research report on Friday, May 2nd. Wall Street Zen upgraded shares of Stryker from a "hold" rating to a "buy" rating in a report on Saturday, June 14th. Finally, Truist Financial lifted their price objective on shares of Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research report on Monday, May 5th. Four research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

Stryker Stock Down 0.4%

Stryker stock opened at $390.67 on Friday. The stock's 50 day moving average price is $378.06 and its 200 day moving average price is $375.38. Stryker Corporation has a 1-year low of $314.93 and a 1-year high of $406.19. The company has a market cap of $149.11 billion, a PE ratio of 52.79, a price-to-earnings-growth ratio of 2.96 and a beta of 0.91. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.64 and a quick ratio of 1.00.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating analysts' consensus estimates of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. During the same quarter last year, the company earned $2.50 earnings per share. Stryker's quarterly revenue was up 11.9% compared to the same quarter last year. On average, sell-side analysts predict that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be paid a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.86%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio (DPR) is 45.41%.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the business's stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the sale, the director now directly owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 5.90% of the company's stock.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.